Pomegranate phytochemical-loaded nanocarriers as therapeutic anti-cancer agents: an in-silico study

Simple item page
dc.contributor.authorNicholas,A. I
dc.contributor.authorDahanayake, J.N
dc.date.accessioned2026-10-26T03:09:42Z
dc.date.available2026-10-26T03:09:42Z
dc.date.issued2025-05
dc.descriptionAbstract No: 2025_344 Page No 82
dc.description.abstractMelanoma, an aggressive skin cancer arising from abnormal melanocytes, is often triggered by UV exposure, showing high heterogeneity and poor prognosis due to rapid metastasis. Synthetic BRAF inhibitors such as Vemurafenib, Dabrafenib, and Encorafenib are approved drugs used to treat metastatic melanoma, which causes adverse side effects.
dc.identifier.issn1012-8999
dc.identifier.urihttps://dr.ichemc.ac.lk/handle/123456789/614
dc.language.isoen
dc.publisherInstitute Of Chemistry Ceylon
dc.relation.ispartofseries42; 2
dc.subjectChitosan
dc.subjectDocking
dc.subjectMelanoma
dc.subjectPomegranate
dc.titlePomegranate phytochemical-loaded nanocarriers as therapeutic anti-cancer agents: an in-silico study
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Pomegranate phytochemical-loaded nanocarriers as therapeutic anti.pdf
Size:
450.17 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Abstract